Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-12-27Clinical Trial Update: Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
A completed clinical trial investigated whether chronic schizophrenia with obsessive-compulsive symptoms is best characterized as comorbidit…
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis [Phase 4]
Phase 4 trial evaluating omega-3 fatty acids for indicated prevention in adolescents with at-risk mental state for psychosis; the study has …
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia [Phase 4]
This Phase 4 trial update reports the completion of a study evaluating quetiapine (Seroquel) as therapy for substance use disorders in patie…
-
CLINICAL_TRIALS trial_result · 2007-12-12Clinical Trial Update: Effects of Atomoxetine on Cognitive Function in Schizophrenia [Phase 2]
A Phase 2 trial evaluating atomoxetine for cognitive function in schizophrenia has completed. The update reports its effects on cognitive ou…
-
CLINICAL_TRIALS trial_result · 2007-12-12Clinical Trial Update: Galantamine for Cognitive Deficits in Schizophrenia [Phase 2, Phase 3]
Update on a Phase 2/Phase 3 clinical trial evaluating galantamine for cognitive deficits in schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating SCA-136 in subjects with acute exacerbations of schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects [Phase 1]
Phase 1 safety and tolerability trial of SCA-136 in healthy Japanese and non-Japanese female subjects has completed; sponsor Wyeth is now a …
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Comparing Bioavailability of Oral Formulations of Vabicaserin [Phase 1]
A Phase 1 bioavailability study comparing oral formulations of vabicaserin in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects [Phase 1]
Wyeth (now a Pfizer subsidiary) completed a Phase 1 study evaluating the safety and tolerability of SCA-136 in healthy Japanese male subject…
-
FDA approval · 2007-11-29FDA Approved: HALOPERIDOL — Original Application (Zydus Lifesciences Limited)
FDA approved HALOPERIDOL from Zydus Lifesciences Limited under an Original Application (ANDA), providing a generic version of haloperidol. T…
-
CLINICAL_TRIALS trial_result · 2007-11-27Clinical Trial Update: Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder [Phase 3]
A Phase 3 trial comparing rapid versus conventional titration of quetiapine in schizophrenia and schizoaffective disorder has been terminate…
-
FDA approval · 2007-11-07FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic combination product perphenazine and amitriptyline hydrochloride by Mylan Pharmaceut…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia [Phase 4]
A completed Phase 4 trial comparing olanzapine to aripiprazole for acutely ill patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder [Phase 3]
Phase 3 trial of olanzapine in adolescents with schizophrenia or Bipolar I disorder has been completed. The trial was sponsored by Eli Lilly…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
Phase 4 trial comparing continuing olanzapine to switching to quetiapine in overweight or obese adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS research · 2007-11-02Clinical Trial Update: Cognitive Remediation in Supported Employment at Human Service Center (HSC) [NA]
This clinical trial update describes a cognitive remediation program used to support employment for individuals with schizophrenia at the Hu…
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of Bacopa monnieri and Nardostachys jatamansi for schizophrenia has completed.
-
FDA approval · 2007-10-02FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-10-02FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA supplemental approval for Geodon (ziprasidone) by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: Metabolic Profile and Anthropometric Changes in Schizophrenia [NA]
A completed clinical trial assessing metabolic profile and anthropometric changes in individuals with schizophrenia, with focus on metabolic…
-
FDA approval · 2007-09-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate (long-acting injectable antipsychotic) submitted by Patriot Pharmaceutical…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Abilify Therapy for Reducing Comorbid Substance Abuse [Phase 4]
Phase 4 trial evaluating aripiprazole (Abilify) for reducing comorbid substance use across multiple psychiatric disorders; the study has com…
-
CLINICAL_TRIALS research · 2007-08-24Clinical Trial Update: Analysis of Genomic DNA Alterations in Familial Schizophrenia
Clinical trial update from National Taiwan University Hospital analyzing genomic DNA alterations in familial schizophrenia.
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia [NA]
This clinical trial evaluated whether high-dose B-complex vitamins improve symptoms in schizophrenia and schizoaffective disorder. The study…
-
CLINICAL_TRIALS trial_result · 2007-08-21Clinical Trial Update: Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points
This entry reports a clinical trial assessing emotional and cognitive abilities in schizophrenia patients at multiple time points. The curre…